Filter search criteria using below inputs
Click on magnifying glass icon to search
Company | Country | Symbol |
---|
Time | Volume | ACAD |
---|---|---|
09:32 ET | 10950 | 14.8901 |
09:34 ET | 29781 | 15.03 |
09:36 ET | 2444 | 14.975 |
09:38 ET | 2000 | 14.98 |
09:39 ET | 1700 | 14.935 |
09:41 ET | 1900 | 14.935 |
09:43 ET | 8580 | 14.925 |
09:48 ET | 1050 | 14.91 |
09:50 ET | 1231 | 14.915 |
09:52 ET | 3510 | 14.9 |
09:54 ET | 1000 | 14.9 |
09:56 ET | 10768 | 14.86 |
09:57 ET | 2408 | 14.86 |
09:59 ET | 1000 | 14.86 |
10:01 ET | 10762 | 14.845 |
10:03 ET | 1407 | 14.84 |
10:06 ET | 1479 | 14.7901 |
10:08 ET | 4923 | 14.79 |
10:10 ET | 6624 | 14.75 |
10:12 ET | 2117 | 14.73 |
10:14 ET | 8301 | 14.77 |
10:15 ET | 2000 | 14.77 |
10:17 ET | 5309 | 14.77 |
10:19 ET | 2741 | 14.8 |
10:21 ET | 1600 | 14.8 |
10:24 ET | 2238 | 14.795 |
10:26 ET | 700 | 14.765 |
10:28 ET | 2900 | 14.78 |
10:30 ET | 1521 | 14.78 |
10:32 ET | 1620 | 14.785 |
10:33 ET | 4668 | 14.81 |
10:35 ET | 2100 | 14.81 |
10:37 ET | 3026 | 14.81 |
10:39 ET | 500 | 14.79 |
10:42 ET | 3978 | 14.8 |
10:44 ET | 1000 | 14.805 |
10:46 ET | 500 | 14.81 |
10:48 ET | 5239 | 14.81 |
10:50 ET | 2926 | 14.805 |
10:51 ET | 3841 | 14.875 |
10:53 ET | 1733 | 14.875 |
10:55 ET | 807 | 14.87 |
10:57 ET | 1089 | 14.845 |
11:00 ET | 3747 | 14.82 |
11:02 ET | 4148 | 14.86 |
11:04 ET | 500 | 14.88 |
11:06 ET | 2992 | 14.885 |
11:08 ET | 1101 | 14.89 |
11:11 ET | 200 | 14.89 |
11:13 ET | 3526 | 14.87 |
11:15 ET | 1386 | 14.84 |
11:18 ET | 4423 | 14.83 |
11:20 ET | 883 | 14.83 |
11:22 ET | 1358 | 14.81 |
11:24 ET | 3551 | 14.8 |
11:26 ET | 5800 | 14.81 |
11:27 ET | 300 | 14.81 |
11:29 ET | 600 | 14.8 |
11:31 ET | 200 | 14.8 |
11:33 ET | 3250 | 14.81 |
11:36 ET | 2500 | 14.81 |
11:38 ET | 1390 | 14.82 |
11:40 ET | 2480 | 14.81 |
11:42 ET | 10338 | 14.84 |
11:44 ET | 812 | 14.86 |
11:45 ET | 2000 | 14.85 |
11:47 ET | 800 | 14.83 |
11:49 ET | 1300 | 14.85 |
11:51 ET | 1500 | 14.82 |
11:54 ET | 200 | 14.83 |
11:56 ET | 1891 | 14.845 |
11:58 ET | 1451 | 14.855 |
12:00 ET | 2100 | 14.845 |
12:02 ET | 3123 | 14.87 |
12:03 ET | 700 | 14.885 |
12:05 ET | 1384 | 14.87 |
12:07 ET | 4137 | 14.875 |
12:09 ET | 1800 | 14.88 |
12:12 ET | 1401 | 14.87 |
12:14 ET | 3399 | 14.885 |
12:16 ET | 3030 | 14.9 |
12:18 ET | 1000 | 14.9099 |
12:20 ET | 1347 | 14.9 |
12:21 ET | 1200 | 14.89 |
12:23 ET | 2828 | 14.89 |
12:25 ET | 4011 | 14.885 |
12:27 ET | 2298 | 14.88 |
12:30 ET | 1607 | 14.895 |
12:32 ET | 755 | 14.89 |
12:34 ET | 2454 | 14.875 |
12:36 ET | 3110 | 14.88 |
12:38 ET | 2521 | 14.885 |
12:39 ET | 3600 | 14.91 |
12:41 ET | 2762 | 14.91 |
12:43 ET | 2265 | 14.915 |
12:45 ET | 4889 | 14.9183 |
12:48 ET | 700 | 14.9023 |
12:50 ET | 1900 | 14.91 |
12:52 ET | 1120 | 14.905 |
12:54 ET | 1799 | 14.9 |
12:56 ET | 1786 | 14.88 |
12:57 ET | 1992 | 14.895 |
12:59 ET | 1250 | 14.905 |
01:01 ET | 2600 | 14.9 |
01:03 ET | 1552 | 14.91 |
01:06 ET | 2399 | 14.95 |
01:08 ET | 3519 | 14.93 |
01:10 ET | 4546 | 14.945 |
01:12 ET | 1704 | 14.96 |
01:14 ET | 1755 | 14.96 |
01:15 ET | 1552 | 14.95 |
01:17 ET | 11093 | 14.95 |
01:19 ET | 2830 | 14.955 |
01:21 ET | 4980 | 14.995 |
01:24 ET | 5531 | 15.005 |
01:26 ET | 829 | 15.005 |
01:28 ET | 700 | 15.01 |
01:30 ET | 15077 | 15.025 |
01:32 ET | 3208 | 15.0248 |
01:33 ET | 7976 | 15.07 |
01:35 ET | 4008 | 15.065 |
01:37 ET | 2985 | 15.055 |
01:39 ET | 3492 | 15.04 |
01:42 ET | 3997 | 15.045 |
01:44 ET | 3211 | 15.045 |
01:46 ET | 3137 | 15.03 |
01:48 ET | 1899 | 15.02 |
01:50 ET | 1971 | 15.005 |
01:51 ET | 600 | 14.99 |
01:53 ET | 3103 | 14.98 |
01:55 ET | 4790 | 15 |
01:57 ET | 4540 | 15.035 |
02:00 ET | 800 | 15.035 |
02:02 ET | 1340 | 15.03 |
02:04 ET | 3895 | 15.03 |
02:06 ET | 1732 | 15.015 |
02:08 ET | 1941 | 15.015 |
02:09 ET | 9002 | 15.055 |
02:11 ET | 4256 | 15.055 |
02:15 ET | 4823 | 15.035 |
02:18 ET | 2571 | 15.03 |
02:20 ET | 4575 | 15.025 |
02:22 ET | 620 | 15.034 |
02:24 ET | 2449 | 15.045 |
02:26 ET | 2199 | 15.045 |
02:27 ET | 1600 | 15.055 |
02:29 ET | 3362 | 15.0501 |
02:31 ET | 4359 | 15.045 |
02:33 ET | 3245 | 15.02 |
02:36 ET | 5300 | 15.05 |
02:38 ET | 701 | 15.06 |
02:40 ET | 2200 | 15.055 |
02:42 ET | 3720 | 15.075 |
02:44 ET | 4300 | 15.055 |
02:45 ET | 1200 | 15.045 |
02:47 ET | 1150 | 15.06 |
02:49 ET | 1300 | 15.065 |
02:51 ET | 504 | 15.0671 |
02:54 ET | 4648 | 15.095 |
02:56 ET | 6400 | 15.095 |
02:58 ET | 7281 | 15.1 |
03:00 ET | 5684 | 15.09 |
03:02 ET | 4242 | 15.06 |
03:03 ET | 6250 | 15.05 |
03:05 ET | 2419 | 15.045 |
03:07 ET | 2944 | 15.075 |
03:09 ET | 1400 | 15.075 |
03:12 ET | 10639 | 15.13 |
03:14 ET | 4696 | 15.095 |
03:16 ET | 2421 | 15.105 |
03:18 ET | 1672 | 15.1 |
03:20 ET | 4293 | 15.1 |
03:21 ET | 3290 | 15.11 |
03:23 ET | 3372 | 15.105 |
03:25 ET | 5898 | 15.06 |
03:27 ET | 1604 | 15.055 |
03:30 ET | 5142 | 15.05 |
03:32 ET | 6586 | 15.065 |
03:34 ET | 2986 | 15.065 |
03:36 ET | 5874 | 15.07 |
03:38 ET | 1200 | 15.055 |
03:39 ET | 2700 | 15.075 |
03:41 ET | 3965 | 15.065 |
03:43 ET | 2297 | 15.0574 |
03:45 ET | 4771 | 15.035 |
03:48 ET | 4618 | 15.025 |
03:50 ET | 2900 | 15.03 |
03:52 ET | 5587 | 15.045 |
03:54 ET | 7348 | 15.06 |
03:56 ET | 16765 | 15.055 |
03:57 ET | 19789 | 15.045 |
03:59 ET | 234958 | 15.1 |
Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
---|---|---|---|
ACADIA Pharmaceuticals Inc | 2.4B | 83.3x | --- |
Azenta Inc | 2.3B | -17.1x | --- |
Guardant Health Inc | 2.7B | -5.4x | --- |
PTC Therapeutics Inc | 2.7B | -5.6x | --- |
Novavax Inc | 2.3B | -4.9x | --- |
Catalyst Pharmaceuticals Inc | 2.4B | 37.5x | --- |
Acadia Pharmaceuticals Inc. is a biopharmaceutical company. The Company is focused on the development and commercialization of medicines that address unmet medical needs in central nervous system (CNS) disorders and rare diseases. It has a portfolio of commercial stage products, in-development product opportunities, and research programs that are designed to address unmet needs in CNS disorders and rare diseases. Its pipeline includes NUPLAZID (pimavanserin), DAYBUE (trofinetide), ACP-101, ACP-204, and Antisense Oligonucleotide (ASO) Programs. NUPLAZID is a selective serotonin inverse agonist/antagonist preferentially targeting the 5-HT2A receptor. NUPLAZID is developed for the treatment for Parkinson's Disease Psychosis. Trofinetide is a novel synthetic analog of the amino-terminal tripeptide of insulin-like growth factor 1 (IGF-1) designed to treat the core symptoms of Rett syndrome by reducing neuroinflammation and supporting synaptic function.
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $2.4B |
---|---|
Revenue (TTM) | $890.5M |
Shares Outstanding | 165.9M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 0.38 |
EPS | $0.18 |
Book Value | $2.62 |
P/E Ratio | 83.3x |
Price/Sales (TTM) | 2.7 |
Price/Cash Flow (TTM) | 58.1x |
Operating Margin | 2.56% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.